Abstract:RNA editing offers the opportunity to introduce either stable or transient modifications to nucleic acid sequence without permanent off-target effects, but installation of arbitrary edits into the transcriptome is currently infeasible. Here, we describe Programmable RNA Editing & Cleavage for Insertion, Substitution, and Erasure (PRECISE), a versatile RNA editing method for writing RNA of arbitrary length and sequence into existing pre-mRNAs via 5′ or 3′ trans-splicing. In trans-splicing, an exogenous template is introduced to compete with the endogenous pre-mRNA, allowing for replacement of upstream or downstream exon sequence. Using Cas7-11 cleavage of pre-mRNAs to bias towards editing outcomes, we boost the efficiency of RNA trans-splicing by 10–100 fold, achieving editing rates between 5–50% and 85% on endogenous and reporter transcripts, respectively, while maintaining high-fidelity. We demonstrate PRECISE editing across 11 distinct endogenous transcripts of widely varying expression levels, showcasing more than 50 types of edits, including all 12 possible transversions and transitions, insertions ranging from 1 to 1,863 nucleotides, and deletions. We show high efficiency replacement of exon 4 of MECP2, addressing most mutations that drive the Rett Syndrome; editing of SHANK3 transcripts, a gene involved in Autism; and replacement of exon 1 of HTT, removing the hallmark repeat expansions of Huntington′s disease. Whole transcriptome sequencing reveals the high precision of PRECISE editing and lack of off-target trans-splicing activity. Furthermore, we combine payload engineering and ribozymes for protein-free, high-efficiency trans-splicing, with demonstrated efficiency in editing HTT exon 1 via AAV delivery. We show that the high activity of PRECISE editing enables editing in non-dividing neurons and patient-derived Huntington’s disease fibroblasts. PRECISE editing markedly broadens the scope of genetic editing, is straightforward to deliver over existing gene editing tools like prime editing, lacks permanent off-targets, and can enable any type of genetic edit large or small, including edits not otherwise possible with existing RNA base editors, widening the spectrum of addressable diseases.

Programmable RNA-guided enzymes for next-generation genome editing

SgRNA Engineering for Improved Genome Editing and Expanded Functional Assays.

Editorial: Genome Editing Goes Beyond CRISPR with the Emergence of 'Bridge' RNA Editing

Programmable RNA base editing via targeted modifications

Prime editing for precise and highly versatile genome manipulation

RNA-mediated programmable DNA cleavage

RNA-Guided Human Genome Engineering via Cas9

Bridge RNAs direct programmable recombination of target and donor DNA

Long sequence insertion via CRISPR/Cas gene-editing with transposase, recombinase, and integrase

Bridge RNAs direct modular and programmable recombination of target and donor DNA

Base editing: precision chemistry on the genome and transcriptome of living cells

Harnessing RNA-based DNA repair pathways for targeted gene editing

Discovery and structural mechanism of DNA endonucleases guided by RAGATH-18-derived RNAs

Programmable RNA writing with trans-splicing

RNA editing with CRISPR-Cas13

Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity

Programmable DNA rearrangements using bridge RNAs

Activation of recombinases at specific DNA loci by zinc-finger domain insertions

Enhancing the RNA Engineering Toolkit

To Cut or Not to Cut: Next-generation Genome Editors for Precision Genome Engineering

Improved genome editing by an engineered CRISPR-Cas12a